ECCO 2019 European Cancer Summit

ECCO 2019 European Cancer Summit

Reaching the 70:35 Vision for cancer – 70% long term survival for all cancer patients across Europe by 2035 – requires breaking down the borders of cancer care: between countries, professions, sectors and stakeholders.

Join us to chart how to make that happen sooner, and be part of the border-breaking community in cancer care!

The ECCO 2019 European Cancer Summit will:

Debate leading-edge ideas in achieving improvement in cancer care
Determine consensus resolutions for improving health care systems
Decide on an action plan for the way forward to ensure ideas translate into policies that will impact daily clinical practice



Why should you attend?

The Summit unites the multidisciplinary community
Share knowledge and drive the debate on achieving improvement in cancer care
Demand the changes required to improve patient outcomes
Engage in resolution-forming to shape the EU cancer policy agenda
Translating ideas into policies that will impact daily clinical practice
Network with leaders from cancer health care, patient advocacy and stakeholder communities
Represent your organisation’s voice to the change-making community of European cancer care

Who should attend?

Current and future leadership and officers from staff and professional levels of:

Representatives of ECCO Member Societies
Patient organisations including patient advocates
Healthcare providers including hospitals, cancer centres and oncology departments
Healthcare insurance providers and other payer organisations
Education providers
Commercial providers to the healthcare sector
EU and national/regional government officials
Public affairs professionals
Elected policy makers in the healthcare sector
Academic researchers
Regulatory professionals

As with all ECCO events, a special feature is the collaboration between our different member societies and ECCO Patient Advisory Committee in producing high-quality, stimulating and illuminating sessions, and providing a platform for neglected aspects in the cancer policy debate to receive attention.